Gingko biloba promising in vascular cognitive impairment

A preliminary study reveals that intravenous injections of ginkgo biloba components could significantly improve early cognitive recovery in ischemic stroke patients.

Conducted across multiple centers in China, the research tested the effects of ginkgo diterpene lactone meglumine (GDLM) on 3,163 stroke survivors, showing notable improvements in cognitive scores compared to a placebo group.

This study suggests that GDLM's neuroprotective properties, including antioxidation and anti-inflammation, may offer a new avenue for enhancing post-stroke cognitive function.

The study's promising results call for more extensive trials to verify the safety and effectiveness of GDLM in stroke recovery, underlining the importance of cautious integration of complementary medicines into cardiovascular care.

Source: American Heart Association/ Neuroscience News